In a curtailed randomized trial of 15 colon cancer patients with resected liver metastases, dendritic cell vaccines loaded with autologous tumor lysates showed a trend toward longer disease-free survival compared to observation, despite the small cohort size ( 117 ).
← all excerpts
Reprogramming dendritic cells to overcome tumor-mediated immune suppression.
1
—
—